199 related articles for article (PubMed ID: 34193946)
1. Dietary interventions to improve body composition in men treated with androgen deprivation therapy for prostate cancer: a solution for the growing problem?
Umlauff L; Weber M; Freitag N; Fairman CM; Heidenreich A; Bloch W; Schumann M
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):149-158. PubMed ID: 34193946
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of multidisciplinary interventions in preventing metabolic syndrome and improving body composition in prostate cancer patients treated with androgen deprivation therapy: A systematic review and meta-analysis.
Yang U; Harikrishna A; Preda V; Chen J
Clin Nutr ESPEN; 2023 Dec; 58():27-49. PubMed ID: 38057016
[TBL] [Abstract][Full Text] [Related]
3. The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis.
Haseen F; Murray LJ; Cardwell CR; O'Sullivan JM; Cantwell MM
J Cancer Surviv; 2010 Jun; 4(2):128-39. PubMed ID: 20091248
[TBL] [Abstract][Full Text] [Related]
4. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
[TBL] [Abstract][Full Text] [Related]
5. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
[TBL] [Abstract][Full Text] [Related]
6. Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence?
Barnes KA; Ball LE; Galvão DA; Newton RU; Chambers SK
Prostate Cancer Prostatic Dis; 2019 May; 22(2):221-234. PubMed ID: 30279584
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
[TBL] [Abstract][Full Text] [Related]
8. Moderators of resistance-based exercise programs' effect on sarcopenia-related measures in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.
Lopez P; Newton RU; Taaffe DR; Winters-Stone K; Galvão DA; Buffart LM
J Geriatr Oncol; 2023 Jun; 14(5):101535. PubMed ID: 37229882
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy.
Haseen F; Murray LJ; O'Neill RF; O'Sullivan JM; Cantwell MM
Trials; 2010 Aug; 11():86. PubMed ID: 20704726
[TBL] [Abstract][Full Text] [Related]
10. Musculoskeletal Responses to Exercise Plus Nutrition in Men with Prostate Cancer on Androgen Deprivation: A 12-Month RCT.
Dalla Via J; Owen PJ; Daly RM; Mundell NL; Livingston PM; Rantalainen T; Foulkes SJ; Millar JL; Murphy DG; Fraser SF
Med Sci Sports Exerc; 2021 Oct; 53(10):2054-2065. PubMed ID: 33867499
[TBL] [Abstract][Full Text] [Related]
11. The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis.
Bigaran A; Zopf E; Gardner J; La Gerche A; Murphy DG; Howden EJ; Baker MK; Cormie P
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):35-48. PubMed ID: 32860010
[TBL] [Abstract][Full Text] [Related]
12. The effects of resistance exercise on body composition and physical function in prostate cancer patients undergoing androgen deprivation therapy: an update systematic review and meta-analysis.
Tian S; Ding M; Sun H
Aging Male; 2022 Dec; 25(1):281-292. PubMed ID: 36382930
[TBL] [Abstract][Full Text] [Related]
13. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials.
Teleni L; Chan RJ; Chan A; Isenring EA; Vela I; Inder WJ; McCarthy AL
Endocr Relat Cancer; 2016 Feb; 23(2):101-12. PubMed ID: 26584972
[TBL] [Abstract][Full Text] [Related]
14. Lifestyle interventions to alleviate side effects on prostate cancer patients receiving androgen deprivation therapy: a meta-analysis.
Ying M; Zhao R; Jiang D; Gu S; Li M
Jpn J Clin Oncol; 2018 Sep; 48(9):827-834. PubMed ID: 30053039
[TBL] [Abstract][Full Text] [Related]
15. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update.
Owen PJ; Daly RM; Livingston PM; Fraser SF
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):137-145. PubMed ID: 28117386
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy before or during androgen-deprivation therapy does not blunt the exercise-induced body composition protective effects in prostate cancer patients: A secondary analysis of two randomized controlled trials.
Newton RU; Mavropalias G; Fragala MS; Kraemer WJ; Häkkinen K; Taaffe DR; Spry N; Joseph D; Galvão DA
Exp Gerontol; 2021 Aug; 151():111427. PubMed ID: 34052346
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and Safety of Physical Exercise to Preserve Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: A Systematic Review.
Cagliari M; Bressi B; Bassi MC; Fugazzaro S; Prati G; Iotti C; Costi S
Phys Ther; 2022 Mar; 102(3):. PubMed ID: 34972863
[TBL] [Abstract][Full Text] [Related]
19. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.
Newton RU; Taaffe DR; Spry N; Gardiner RA; Levin G; Wall B; Joseph D; Chambers SK; Galvão DA
BMC Cancer; 2009 Jun; 9():210. PubMed ID: 19563641
[TBL] [Abstract][Full Text] [Related]
20. Persisting adverse body composition changes 2 years after cessation of androgen deprivation therapy for localised prostate cancer.
Cheung AS; Tinson AJ; Milevski SV; Hoermann R; Zajac JD; Grossmann M
Eur J Endocrinol; 2018 Jul; 179(1):21-29. PubMed ID: 29712718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
